News

Oxford Square Capital Corp. Launches New $65 Million Offering

Oxford Square Capital Corp. Launches New $65 Million Offering

Oxford Square Capital Corp. Announces New Bond Offering

Oxford Square Capital Corp. (NASDAQ: OXSQ) has recently made headlines with its announcement of a public offering worth $65 million in unsecured notes. These notes will bear an interest rate of 7.75% per year, with quarterly payments beginning on October 31, 2025. This offering marks a significant step for the company as it aims to bolster its financial strategies and investment opportunities.

Details of the Offering

The newly issued notes are scheduled to mature on July 31, 2030. Investors can anticipate the possibility of redeeming the notes in full or part starting from July 31, 2027. This flexibility is designed to appeal to investors seeking both security and potential for returns within a defined timeframe.

Planned Utilization of Proceeds

Funding raised from this offering is intended for several key initiatives. The company plans to utilize the net proceeds to pay down existing debt, acquire further investments aligning with its investment objectives, and cover general corporate expenses. This structured financial planning indicates a proactive approach to managing investments effectively.

Closing Prospects and Underwriters

The closing of this offering is expected to occur shortly, subject to standard closing conditions. Oxford Square has also granted its underwriters an option to purchase an additional $9.75 million in notes. Notably, the notes are anticipated to be listed on the NASDAQ Global Select Market under the trading symbol 'OXSQH,' with trading likely commencing within 30 days of the issue date.

Management and Strategy

Leading the offering are Lucid Capital Markets, LLC and Piper Sandler & Co. as joint book-running managers. Other prominent financial institutions are participating as lead managers, showcasing Oxford Square’s strategic partnerships with key players in the financial sector.

Investment Focus of Oxford Square

Oxford Square Capital Corp. primarily focuses on investing in syndicated bank loans while also participating in debt and equity tranches of collateralized loan obligations (CLOs). This diverse investment strategy positions the company to capitalize on various market opportunities.

Company Overview

Oxford Square Capital Corp. is recognized as a publicly-traded business development company. Its investment model involves prioritizing secured loans and exploring other debt structures that can yield substantial returns while mitigating risks associated with equity financing. The company continues to demonstrate its commitment to providing robust returns to shareholders through innovative and strategic financial practices.

For any inquiries, interested parties can reach out directly to Bruce Rubin at 203-983-5280 for additional information regarding this offering. The investment community is keenly observing these developments, as they signal Oxford Square’s position in the market and its future growth potential.

Frequently Asked Questions

1. What is the interest rate on the new notes issued by Oxford Square Capital Corp.?

The new unsecured notes will bear an interest rate of 7.75% per year.

2. When will the notes start yielding interest payments?

The first interest payment will occur on October 31, 2025, following the issuance of the notes.

3. What will the proceeds from the offering be used for?

Proceeds will be used to repay debt, acquire investments, and for general corporate purposes.

4. Who are the underwriters for this offering?

Lucid Capital Markets, LLC and Piper Sandler & Co. are the joint book-running managers for this offering.

5. Where can investors find more information about Oxford Square's investment focus?

Further information regarding investment strategies can be accessed via their official communications or by contacting the management directly.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Bascom's $30.8M Vegas Refi Amid Market Hurdles

Updated Category News Views 103

Diving into the Vegas Real Estate Scene Alright, folks, let's roll up our sleeves and talk about something that's got my attention—Bascom Group's recent $30.8 million refinance of the Gateway Villas Apartments in Las Vegas. This ain't just another vanilla transaction in the back pages of some real estate journal. It's a play that screams strategy, especially in a world...

Continue Reading
Tamagotchi Turns 30: Roblox Event Connects Worlds

Updated Category News Views 54

A New Chapter for an Old Favorite Dust off your digital pets, folks! Tamagotchi is not just a thing of the past. It's busting out of its shell to celebrate a big 3-0 with a splash—and get this—on Roblox. Who would've thought a plastic egg with pixels would still be out there thriving in the ether of childhood nostalgia three decades later? But it is, and it’s taking...

Continue Reading
SK Bio Pushes FDA Approval for Cenobamate in Seizures

Updated Category News Views 66

Taking New Strides in Epilepsy Treatment Today, we’ve got SK Biopharmaceuticals banging on the FDA’s door with a pile of paperwork. They’re pushing for the green light on cenobamate to tackle primary generalized tonic-clonic (PGTC) seizures, plus expand its use to pediatric patients with the focal-onset seizure condition. Now, if you think it sounds like a big...

Continue Reading
Nomad Foods' Battle with Margins Amid Flat Volumes

Updated Category News Views 73

Subtle Winds of Change in Nomad Foods' Financials Ah, Nomad Foods—Europe's frozen food titan, trotting out its third quarter numbers like a well-rehearsed production line. You've got your slight revenue bump of 2.3% on reported streams, hitting €770 million. But dig a little deeper and you find organic revenue doing a waltz at 1.6% year-on-year, surprising no one...

Continue Reading
Vehicle Reliability Hinges on Design and Maintenance

Updated Category News Views 25

Why Some Cars Age Like Fine Wine—and Some Don't Here’s the thing—cars aren’t all made equal, and anybody who's tinkered around under the hood for a few years long knows that some vehicles just can’t hold it together as time marches on. Now, this ain't rocket science, but the truth is wrapped up in the complexity of designs and those pesky little maintenance...

Continue Reading
Brazilian Jiu-Jitsu's Ground Game: Real-World Self-Defense

Updated Category News Views 55

From Mat to Reality: Brazilian Jiu-Jitsu's Claim to Fame It ain't all high kicks and flashy moves when it comes to self-defense, folks. Enter Brazilian Jiu-Jitsu (BJJ)—an art that's not just about show but about practical, gritty reality. Ever been curious why this discipline is hailed for self-defense? Wayne Marble, a seasoned martial arts expert, dishes out the why's...

Continue Reading
Doppel's Strategic Expansion: Adding PropRise Innovators

Updated Category News Views 46

Doppel Boosts Its Team with PropRise Founders The market doesn’t lie: when a company's on a roll, you watch it closely. Doppel's latest move is a serious signal. They've snagged PropRise, a sprightly Y Combinator graduate, and landed its founders, Jean-Michael Diei and Matthew Krager, right into their engineering fold. These guys aren't greenhorns—cutting their teeth...

Continue Reading
ALS Research Gains Momentum as ACT for ALS Law Signed

Updated Category News Views 64

A Major Stride in ALS Advocacy Today's not your usual day at the office for the folks championing the fight against ALS. With the President putting pen to paper, the ACT for ALS Act just turned into law, sending ripples through the community. Let me tell ya, legislation like this doesn't float by on a cloud—it's the result of grit, sleepless nights, and a dash of...

Continue Reading
Sentra Snags $150M to Shield Data in AI Era

Updated Category News Views 237

Agents in the Data Game Who would've thought data would need protection from its own minders? That's what Sentra's addressing with their smart pivot to 'agentic' data security. AI agents are out there gobbling data faster than a trader overdosing on coffee during a bull run. As AI's pace accelerates, Sentra spotted an opportunity to safeguard data from unauthorized eyes....

Continue Reading
A Journey Through Mongolia's Wilderness and Self-Discovery

Updated Category News Views 78

A Late-Life Adventure Without Borders We all hit that age where adventure seems just a memory—until something shakes us from our slumber, just like Betsy Cooksey’s wild ride into Mongolia. At an age when most tether their dreams to sunlit porches and grandkids' photos, Cooksey grabbed life by the reins. First, though, we gotta talk about the absolute gamble she took....

Continue Reading

Top 5 Most Recently Viewed Articles

FDA Priority Review: Precigen's Innovative Therapy for RRP

Updated Category News Views 399

FDA's Priority Review: A Game Changer for RRP Treatment The FDA has granted a priority review designation to Precigen, Inc. for its biologics license application (BLA) concerning PRGN-2012, a groundbreaking therapy targeting adults suffering from recurrent respiratory papillomatosis (RRP). This fast-tracked review reduces the evaluation timeline to just six months,...

Continue Reading
GCL Global Expands Influence through Ban Leong Acquisition Bid

Updated Category News Views 181

GCL Global's Strategic Move in the Gaming Industry Recently, GCL Global Holdings Ltd. (NASDAQ: GCL), a prominent entity in the entertainment sector, took a significant step by declaring its bid for Ban Leong Technologies Limited unconditional. This decision marks a pivotal moment for GCL and highlights its ambition to expand its reach within the gaming market. Key Aspects...

Continue Reading
Investors of Iris Energy Limited May Pursue Legal Action Now

Updated Category News Views 148

Investors of Iris Energy Limited Have a Legal Opportunity There's a significant opportunity for individuals who have invested in Iris Energy Limited (NASDAQ: IREN) to take action following allegations of securities fraud. The Rosen Law Firm, known for defending investor rights on a global scale, is urging those who purchased shares during a specified period to consider...

Continue Reading
Unveiling Exciting New Beauty Brands at QVC This Year

Updated Category News Views 169

Discover New Brands This Year at QVC As we step into a fresh year, QVC is excited to add vibrant new brands to its beauty and wellness collection, enhancing the self-care journey for its dedicated customers. This month, QVC introduces Love Wellness, No Makeup Makeup, and Gatineau Skincare – all set to redefine beauty routines. The Launch of Love Wellness Founded by Lo...

Continue Reading
Autodesk Executive's Significant Share Sale: Insights and Updates

Updated Category News Views 87

Insight into Autodesk Executive’s Share Sale Recently, Mary T. McDowell, a director at Autodesk, Inc. (NASDAQ: ADSK), sold 550 shares of the company's stock for $265.50 each. This sale brought in more than $146,000, as indicated in a filing with the Securities and Exchange Commission. The market closely watches these insider trades because they can offer clues about...

Continue Reading